[1]
“Sodium-glucose cotransporter 2 inhibition in patients with liver cirrhosis and diabetes: a possible role in ascites control?”, Ital J Med, vol. 18, no. 4, Nov. 2024, doi: 10.4081/itjm.2024.1829.